Sachin Kumar Singh Chauhan

Mr. Sachin Kumar Singh Chauhan

ATMP GMP Development Unit, Institut für zelltherapeutika, Medizinische Hochschule Hannover (MHH),Feodor-Lynen-Str. 21
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
SSSubhashis Sarkar
Subhashis Sarkar
Sachin Kumar Singh ChauhanSachin Kumar Singh Chauhan
Sachin Kumar Singh Chauhan
JDJohn Daly
John Daly
ANAlessandro Natoni
Alessandro Natoni
HFHeather Fairfield
Heather Fairfield
MOMichael O'Dwyer
Michael O'Dwyer

6 July 2020 in Cancers
Verified
Journal Article
Open access
Sachin Kumar Singh ChauhanSachin Kumar Singh Chauhan
Sachin Kumar Singh Chauhan
UKUlrike Koehl
Ulrike Koehl
SKStephan Kloess
Stephan Kloess
During the host immune response, the precise balance of the immune system, regulated by immune checkpoint, is required to avoid infection and cancer. These immune checkpoints are the mainstream regulator of the immune response and are crucial for self-tolerance. During the last decade, various new immune checkpoint molecules have been studied, providing an attractive path to evaluate their potential role as targets for effective therapeutic interventions. Checkpoint inhibitors have mainly been explored in T cells until now, but natural killer (NK) cells are a newly emerging target for the determination of checkpoint molecules. Simultaneously, an increasing number of therapeutic dimensions have been explored, including modulatory and inhibitory checkpoint molecules, either causing dysfunction or promoting effector functions. Furthermore, the combination of the immune checkpoint with other NK cell-based therapeutic strategies could also strengthen its efficacy as an antitumor therapy. In this review, we have undertaken a comprehensive review of the literature to date regarding underlying mechanisms of modulatory and inhibitory checkpoint molecules.

19 December 2025 in STAR Protocols
Verified
Journal Article
Open access
Sachin Kumar Singh ChauhanSachin Kumar Singh Chauhan
Sachin Kumar Singh Chauhan
LFLinda Feldbrügge
Linda Feldbrügge
MSMoritz Schmelzle
Moritz Schmelzle
HWHeiner Wedemeyer
Heiner Wedemeyer
BHBernd Heinrich
Bernd Heinrich
Mononuclear cells from human liver tissue, including tumor and non-tumor regions, are a valuable source for studies of the tumor microenvironment. Here, we present a protocol to dissociate liver tissue from patients with hepatocellular carcinoma. We provide steps to generate single-cell suspension using either mechanical or enzymatic digestion, following steps for separating mononuclear cells using density gradient. Finally, we describe steps for flow cytometry staining of isolated immune cells. For complete details on the use and execution of this protocol, please refer to Moreno-Fernandez et al.1 and Heinrich et al.2.